New Management Appointed at Greiner Bio-One International AG and Greiner Bio–One GmbH

Monroe, NC (I-Newswire) December 12, 2011 - Axel Kühner took over the vacant position of the Managing Director of Greiner Bio-One GmbH on an interim basis at the end of August in his capacity as Chief Executive Officer of Greiner Bio-One International AG. He has now established a successor. “Following three months of intensive discussions I have now decided on a completely new management solution for Greiner Bio-One. We possess very good management personalities within our group. This is why I decided on a succession from our own ranks. All the Management Board members are bringing in the competence and experience essential for leading this company into a continued successful future”, Axel Kühner said.

A management board with a single voice

The new Management Board is comprised of four key area specialists: Rainer Perneker, production and technique, Manfred Buchberger, business unit Preanalytics, Heinz Schmid, business unit BioScience, and Georg Heftberger, finance. Rainer Perneker will be spokesperson of the Management Board. The new management team will direct the operative business under the two Chairmen of Greiner Bio-One International AG, Axel Kühner (CEO) and Hannes Moser (CFO) from January 1st 2012.

Subsidiaries to stay independent

The two subsidiary companies Greiner Bio-One GmbH Austria and Greiner Bio-One GmbH Germany will remain independent units. In the management of both of these companies Rainer Perneker will be responsible for production and Georg Heftberger for finance. The management spokesperson will be Manfred Buchberger for Austria and Heinz Schmid for Germany.

Personalities with great experience and competence

Rainer Perneker (42) began his career with C.A. Greiner & Söhne KG in 1984. In addition to building up the technical development for Labortechnik, his experience also includes the planning and development of the production locations in the USA and Brazil.
Manfred Buchberger (53) has been active in Greiner Bio-One GmbH sales in Kremsmünster since 1990. He is Sales Director for Preanalytics and in the management for France, Switzerland and China.

Heinz Schmid (52) began as Assistant to the Sales Director at C.A. Greiner & Söhne GmbH in Nürtingen (Germany) in 1978. He was Sales Director and Commercial Director until his promotion to CEO of Greiner Bio-One GmbH Frickenhausen in 2006.

Georg Heftberger (33) was Assistant to the Greiner Holding AG Board of Directors in 2009 and was then responsible for corporate strategy and corporate development.

More on Greiner Bio-One

The independent Greiner Bio-One International AG emerged from the splitting of the Labortechnik Division from Greiner Holding AG in 2001 and concentrates on business fields that are highly promising for the future Preanalytics and BioScience. The company is owned by the Greiner family and by Greiner Holding AG (11.16%) and employs over 1,600 employees. A turnover of 311 million euros was achieved in 2010. The Chairmen of Greiner Bio-One International AG (GBO Int. AG) are Dipl.-Bw. Axel Kühner (CEO) and Mag. Hannes Moser (CFO). The Management Board of GBO Int. AG will be Rainer Perneker (spokesperson), Manfred Buchberger, Heinz Schmid and Georg Heftberger as of 1.1.2012. The operative subsidiaries of GBO Int. AG are Greiner Bio-One GmbH Austria (Kremsmünster), Greiner Bio-One GmbH Germany (Fricken-hausen) and Mediscan GmbH & Co KG.

About Greiner Bio- One North America, Inc.:
Greiner Bio-One North America, Inc., located in Monroe, North Carolina, provides product manufacturing, distribution logistics and product application support to our customers. The North American operation is a wholly-owned subsidiary of Greiner Bio-One International AG.

The BioScience business operation of Greiner Bio-One offers products for the cultivation and analysis of cell and tissue cultures, microplates for high-throughput screening, allowing industry and research the most rapid and efficient drug screening, a complete line of dependable ready-to-use general labware tools used laboratories everywhere, and innovative biochip technologies for genotyping to detect gene defects and identify infectious agents.

In addition to supplying commercial products Greiner Bio-One offers Tailor-made Solutions of customized plastic platforms for the life sciences sector.

Company Contact Information
Greiner Bio- One North America, Inc.
Mackenzie Farone
4238 Capital Drive, Monroe NC
28110
Phone : 7042617860